14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.22 $6.22 Friday, 27th Jan 2023 LJPC stock ended at $6.22. During the day the stock fluctuated 0% from a day low at $6.22 to a day high of $6.22.
90 days $6.22 $6.22
52 weeks $3.07 $6.24

Historical La Jolla Pharmaceutical Company prices

Date Open High Low Close Volume
Oct 10, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 07, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 06, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 05, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 04, 2022 $6.22 $6.22 $6.22 $6.22 0
Oct 03, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 30, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 29, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 28, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 27, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 26, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 23, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 22, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 21, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 20, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 19, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 16, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 15, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 14, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 13, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 12, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 09, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 08, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 07, 2022 $6.22 $6.22 $6.22 $6.22 0
Sep 06, 2022 $6.22 $6.22 $6.22 $6.22 0
Click to get the best stock tips daily for free!

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age ... LJPC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT